Join
Live feed
·
PRReleasevia Quantisnow
Exicure Inc. logo

Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
XCUR· Exicure Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XCUR (Exicure Inc.) and more on Quantisnow.